Read More Pharma Industry News Canada approves GSK’s Arexvy vaccine for RSV protection in adults 50-59 at elevated risk In a crucial development for public health, Health Canada has extended its approval for GlaxoSmithKline’s Arexvy vaccine to… byPallavi MadhirajuNovember 7, 2024